Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. logo

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (1349)

Market Open
24 Feb, 07:59
HKEX HKEX
3. 20
HKD
-0.03
-0.93%
HKD
- Market Cap
- P/E Ratio
0.09% Div Yield
849,000 Volume
0 Eps
3.23 HKD
Previous Close
Day Range
3.17 3.24
Year Range
2.13 5.29
Want to track 1349 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
1349 earnings report is expected in 35 days (31 Mar 2026)

Summary

1349 trading today lower at 3.2 HKD, a decrease of 0.93% from yesterday's close, completing a monthly decrease of -0.93% or 0.03 HKD. Over the past 12 months, 1349 stock gained 15.11%.
1349 pays dividends to its shareholders, with the most recent payment made on Aug 25, 2025. The next estimated payment will be in In 6 months on Aug 25, 2026 for a total of 0.0321 HKD.
The last earnings report, released on Aug 11, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Mar 31, 2026.
The stock of the company had never split.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on XBER (EUR).

1349 Chart

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (1349) FAQ

What is the stock price today?

The current price is 3.20 HKD.

On which exchange is it traded?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. is listed on XBER.

What is its stock symbol?

The ticker symbol is 1349.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.09%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Mar 31, 2026.

Has Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
- CEO
HKEX Exchange
- ISIN
Germany Country
- Employees
10 Jul 2025 Last Dividend
- Last Split
- IPO Date
There is no Profile data available for FDY.BE.

Contact Information